The increasing demand for specific immunological investigation and therapeutic development has spurred significant improvements in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using diverse expression platforms, including bacterial hosts, higher cell populati